Actemra 200mg, a drug known scientifically as tocilizumab, represents a potent biologic agent primarily employed for the control of rheumatoid arthritis. This effective substance functions by inhibiting the activity of interleukin-6 (IL-6), a regulatory protein vital in the inflammatory process. Moreover, Actemra exhibits effectiveness in the mana